Toll-Like Receptor 9 Agonists for Cancer Therapy

The immune system has acquired increasing importance as a key player in cancer maintenance and growth. Thus, modulating anti-tumor immune mediators has become an attractive strategy for cancer treatment. Toll-like receptors (TLRs) have gradually emerged as potential targets of newer immunotherapies....

Descripción completa

Detalles Bibliográficos
Autores principales: Melisi, Davide, Frizziero, Melissa, Tamburrino, Anna, Zanotto, Marco, Carbone, Carmine, Piro, Geny, Tortora, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344222/
https://www.ncbi.nlm.nih.gov/pubmed/28548068
http://dx.doi.org/10.3390/biomedicines2030211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344222/
https://www.ncbi.nlm.nih.gov/pubmed/28548068
http://dx.doi.org/10.3390/biomedicines2030211

Ejemplares similares